Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    5 0 0 0

Archives de pédiatrie
Volume 10, n° S3
pages 490-494 (août 2003)
Doi : S0929-693X(03)90016-9
Question 5 Quelle prise en charge de l'átteinte hepatobiliaire au cours de la mucoviscidose? Stratégie thérapeutique spécifique de 1' atteinte hépatobiliaire au cours de la mucoviscidose

D. Debray
Service d'hépatologie pédiatrique, hôpital de Bicetre, 78, rue du Général Leclerc, 94275 Le Kremlin-Bicêtre cedex, France 

Mots-clé : Atteinte hépatobiliaire, Mucoviscidose

Keywords : Liver disease, Cystic fibrosis

© 2003  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline